DrugCite
Search

CIFLOX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Ciflox Adverse Events Reported to the FDA Over Time

How are Ciflox adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ciflox, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ciflox is flagged as the suspect drug causing the adverse event.

Most Common Ciflox Adverse Events Reported to the FDA

What are the most common Ciflox adverse events reported to the FDA?

Renal Failure Acute
80 (2.53%)
Pyrexia
79 (2.49%)
Rash Maculo-papular
55 (1.74%)
Thrombocytopenia
54 (1.7%)
Drug Rash With Eosinophilia And Sys...
46 (1.45%)
Eosinophilia
43 (1.36%)
Toxic Skin Eruption
43 (1.36%)
Anaemia
40 (1.26%)
Cytolytic Hepatitis
40 (1.26%)
Cholestasis
35 (1.1%)
International Normalised Ratio Incr...
33 (1.04%)
Show More Show More
Pruritus
33 (1.04%)
Rash
33 (1.04%)
Renal Failure
33 (1.04%)
Confusional State
32 (1.01%)
Erythema
32 (1.01%)
Agranulocytosis
30 (.95%)
Purpura
30 (.95%)
Neutropenia
28 (.88%)
Skin Exfoliation
28 (.88%)
Hallucination
25 (.79%)
Leukopenia
25 (.79%)
Toxic Epidermal Necrolysis
25 (.79%)
Diarrhoea
24 (.76%)
Pancytopenia
23 (.73%)
Asthenia
21 (.66%)
Drug Interaction
21 (.66%)
General Physical Health Deteriorati...
20 (.63%)
Alanine Aminotransferase Increased
19 (.6%)
Stevens-johnson Syndrome
18 (.57%)
Acute Generalised Exanthematous Pus...
17 (.54%)
Condition Aggravated
17 (.54%)
Hepatitis
17 (.54%)
Hyperkalaemia
17 (.54%)
Oedema Peripheral
17 (.54%)
Vascular Purpura
17 (.54%)
Vomiting
17 (.54%)
Aspartate Aminotransferase Increase...
16 (.51%)
Dermatitis Exfoliative
16 (.51%)
Rash Erythematous
16 (.51%)
Transaminases Increased
16 (.51%)
Chills
15 (.47%)
Haematoma
15 (.47%)
Multi-organ Failure
15 (.47%)
Anuria
14 (.44%)
Blood Creatinine Increased
14 (.44%)
Cough
14 (.44%)
Nausea
14 (.44%)
Arthralgia
13 (.41%)
Dehydration
13 (.41%)
Face Oedema
13 (.41%)
Gamma-glutamyltransferase Increased
13 (.41%)
Haematuria
13 (.41%)
Hepatitis Cholestatic
13 (.41%)
Rash Morbilliform
13 (.41%)
Abdominal Pain
12 (.38%)
Hyperthermia
12 (.38%)
Lung Disorder
12 (.38%)
Odynophagia
12 (.38%)
Oedema
12 (.38%)
Status Epilepticus
12 (.38%)
Weight Decreased
12 (.38%)
Cerebral Haemorrhage
11 (.35%)
Clostridium Difficile Colitis
11 (.35%)
Coma
11 (.35%)
Convulsion
11 (.35%)
Death
11 (.35%)
Delirium
11 (.35%)
Disorientation
11 (.35%)
Fall
11 (.35%)
Hypotension
11 (.35%)
Jaundice
11 (.35%)
Sepsis
11 (.35%)
Tachycardia
11 (.35%)
Agitation
10 (.32%)
Blood Alkaline Phosphatase Increase...
10 (.32%)
C-reactive Protein Increased
10 (.32%)
Dermatitis Bullous
10 (.32%)
Drug Hypersensitivity
10 (.32%)
Haemoglobin Decreased
10 (.32%)
Hypersensitivity
10 (.32%)
Inflammation
10 (.32%)
Pain In Extremity
10 (.32%)
Prothrombin Level Decreased
10 (.32%)
Rash Generalised
10 (.32%)
Rectal Haemorrhage
10 (.32%)
Respiratory Distress
10 (.32%)
Tendon Disorder
10 (.32%)
Blood Creatine Phosphokinase Increa...
9 (.28%)
Cheilitis
9 (.28%)
Drug Eruption
9 (.28%)
Dysphagia
9 (.28%)
Dyspnoea
9 (.28%)
Hepatic Failure
9 (.28%)
Pancreatitis Acute
9 (.28%)
Peritoneal Haemorrhage
9 (.28%)
Respiratory Failure
9 (.28%)
Shock
9 (.28%)
Urinary Tract Infection
9 (.28%)
Cholangitis
8 (.25%)
Conjunctivitis
8 (.25%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Ciflox, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ciflox is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ciflox

What are the most common Ciflox adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ciflox, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ciflox is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Ciflox According to Those Reporting Adverse Events

Why are people taking Ciflox, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
105
Urinary Tract Infection
55
Prostatitis
30
Product Used For Unknown Indication
28
Osteitis
22
Lung Disorder
22
Show More Show More
Infection
17
Pyelonephritis
16
Unevaluable Event
15
Septic Shock
14
Sepsis
11
Bronchitis
11
Pyrexia
11
Pseudomonas Infection
10
Pneumonia
9
Hyperthermia
9
Respiratory Tract Infection
8
Prophylaxis
8
Erysipelas
8
Diabetic Foot
7
Orchitis
6
Klebsiella Infection
6
Pulmonary Tuberculosis
5
Pyelonephritis Acute
5
Febrile Bone Marrow Aplasia
5
Cystitis
4
Antibiotic Prophylaxis
4
Tuberculosis
4
Superinfection Lung
4
Escherichia Infection
4
Infection Prophylaxis
4
Osteoarthritis
4
Alveolitis
4
Lung Infection
4
Antibiotic Therapy
4
Enterobacter Infection
3
Urinary Tract Disorder
3
Cellulitis
3
Crohns Disease
3
Head Injury
3
Gastroenteritis
3
Wound Infection
3
Osteonecrosis
3
Pouchitis
3
Arthritis Bacterial
3
Bacterial Pyelonephritis
3
Eczema
3
Escherichia Sepsis
3
Device Related Infection
3
Rectal Abscess
2
Bile Duct Stone
2

Ciflox Case Reports

What Ciflox safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Ciflox. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Ciflox.